A Medigene platform · Omnichannel HCP engagement

One knowledge network for everyone in the care chain

A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.

Who MedShorts servesProgrammes for pharma

The MedShorts network

DoctorsClinical updates in five minutes or less
PharmacistsDispensing, counselling and safety capsules
Field forceProduct knowledge, certification and shareable links
One dashboardReach, engagement and learning, by audience
MedShorts 360 · Latest

Latest news, 12 November 2026

One new story for each specialty, every morning: short, sourced and readable between patients.

CardiologyCardiology

HD-PCI trial: heparin 70 U/kg and 100 U/kg give similar 30-day outcomes in elective PCI

In a Canadian cluster-crossover trial of 11,619 elective PCI patients, 70 U/kg and 100 U/kg unfractionated heparin gave similar 30-day rates of death, MI or revascularisation and of major bleeding, although the trial was underpowered.

TCTMD
DiabetologyDiabetology

Indian phase 3 trial: dapagliflozin-glimepiride-metformin FDC lowers HbA1c more than dual therapy

In a 536-patient open-label Indian phase 3 trial, a twice-daily dapagliflozin, glimepiride and metformin fixed-dose tablet cut HbA1c by 2.17 to 2.25 percentage points at 16 weeks, versus 1.64 to 1.72 points with glimepiride plus metformin.

Medical Dialogues
NephrologyNephrology

Aortic arch calcification on routine chest CT linked to higher mortality in haemodialysis patients

In 205 maintenance haemodialysis patients followed for a mean of 61 months, a higher aortic arch calcification score measured on non-gated chest CT independently predicted cardiovascular and all-cause death, a BMC Nephrology study reports.

Medical Dialogues
NeurologyNeurology

US FDA investigates tumour risk from vector integration after onasemnogene abeparvovec for SMA

The US FDA is investigating postmarketing reports of insertional oncogenesis involving the GLI1 gene after onasemnogene abeparvovec gene therapy for spinal muscular atrophy, and advises monitoring treated patients for tumours.

NeurologyLive
UrologyUrology

Updated ASTRO guideline backs moderate hypofractionation for localised prostate cancer in all risk groups

An updated ASTRO guideline, developed with ASCO, AUA, ESTRO and SUO, recommends moderate hypofractionation over conventional fractionation for localised prostate cancer and supports five-fraction ultrahypofractionation for selected low- and intermediate-risk patients.

Urology Times
PsychiatryPsychiatry

Pune RCT: 45 days of the Common Yoga Protocol improves mood and sleep quality in healthy adults

An open-label Indian randomised trial in 139 healthy adults found that 45 days of the Common Yoga Protocol improved positive and negative affect, sleep quality and some short-term memory measures compared with a waitlist control.

News-Medical
PulmonologyPulmonology

Tamil Nadu's differentiated TB care programme linked to 38–56% fall in TB deaths: ICMR-NIE analysis

An ICMR-NIE and Tamil Nadu State TB Cell evaluation in BMJ Global Health reports that triaging adults with drug-sensitive TB using five bedside parameters was followed by TB death rates falling from 6.3% to between 3.9% and 2.8%.

ThePrint (PTI)
Critical CareCritical Care

Indian review: supraclavicular ultrasound confirms central line tip position in over 99% of adults

A systematic review in the Indian Journal of Anaesthesia pooled five observational studies of 252 adults and found real-time right supraclavicular ultrasound achieved correct central venous catheter tip placement in 99.16%, with most malpositions corrected at the bedside.

Medical Dialogues
GastroenterologyGastroenterology

NEJM trial: 5-year colonoscopy surveillance after high-risk adenoma removal non-inferior to 3-year

Interim results of a European randomised trial in 10,799 patients show that first surveillance colonoscopy at 5 years after removal of high-risk adenomas gave colorectal cancer incidence similar to surveillance at 3 years (0.77% vs 0.82%).

Healio
DermatologyDermatology

Two-year extension data: dupilumab keeps severe atopic dermatitis controlled in children under six

In the LIBERTY AD PED open-label extension, 121 children aged 6 months to 5 years with severe atopic dermatitis on monthly weight-based dupilumab had sustained skin and quality-of-life gains for up to two years, with no new safety signals.

Medical Dialogues
OphthalmologyOphthalmology

Colder weather linked to slightly higher eye pressure in treated glaucoma, Japanese study finds

A Japanese records study (2012 to 2023) of 154 eyes with stable, medically treated open-angle glaucoma found lower air temperature was independently linked to higher intraocular pressure, mainly in severe disease or patients on several drops.

Medical Dialogues
ENTENT

Endoscopic frontal sinus surgery matched to disease extent improves nasal polyposis scores at six months

In a prospective study of 62 adults with nasal polyposis undergoing Draf I to III frontal sinus surgery, CT, symptom and quality-of-life scores improved markedly by six months with all four approaches.

Medical Dialogues
OrthopaedicsOrthopaedics

Indian review outlines stepwise, team-based control of bleeding in unstable pelvic ring injuries

A narrative review in the Indian Journal of Orthopaedics recommends early tranexamic acid, immediate pelvic binders, preperitoneal packing and angioembolisation within standard institutional protocols for haemodynamically unstable pelvic fractures.

Medical Dialogues
GynaecologyGynaecology

Indian study of 650 ectopic pregnancies compares laparoscopic surgery with methotrexate outcomes

In a retrospective Indian tertiary-centre series of 650 women with ectopic pregnancy, laparoscopy had higher success than methotrexate, while medical treatment meant shorter stays and fewer transfusions.

Medical Dialogues
PaediatricsPaediatrics

Apollo Medicine review: modern protocols push childhood ALL survival above 90% in specialised centres

A review by Delhi paediatric haemato-oncologists says risk stratification, MRD monitoring and immunotherapy have lifted childhood ALL survival above 90% in specialised centres, while cost still limits access in India.

Medical Dialogues
SurgerySurgery

BMJ trial: omitting morning ACE inhibitor or ARB dose cuts hypotension during non-cardiac surgery

In a placebo-controlled trial of 2,012 older adults with hypertension, skipping the surgery-day ACE inhibitor or ARB dose lowered intraoperative hypotension from 45.5% to 31.2%, with no difference in 30-day complications or death.

News-Medical
General MedicineGeneral Medicine

ISCHEMIA-EXTEND: routine invasive strategy gives no survival gain over medical therapy at 11 years

Long-term follow-up of 5,179 ISCHEMIA patients with stable coronary disease found similar 11-year all-cause mortality with routine invasive or initial conservative management (25.8% vs 26.9%).

JAMA
17 new today · 17 latest storiesSee all MedShorts 360 stories →
Get the MedShorts app

Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.

Why MedShorts is changing

Medical communication has outgrown the single doctor visit

Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.

MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.

The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.

What changes with MedShorts

01
From one audience to threeContent written separately for prescribers, dispensers and representatives, from the same evidence base.
02
From campaigns to a programmeA planned calendar of short updates across the year instead of one-off mailers.
03
From clicks to insightEngagement data by specialty, geography and audience, fed back into the next cycle.
04
From information to learningQuizzes, certification and links to Medigene CME where a deeper course exists.
Who MedShorts serves

Built for three roles that shape every treatment

Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.

For doctors

Clinical knowledge between consultations

Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.

  • Read or watch in under five minutes
  • Specialty-specific libraries
  • Patient education material to share
MedShorts for doctors →
For pharmacists

Confident counselling at the counter

Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.

  • Counselling scripts and checklists
  • Drug interaction and safety alerts
  • Available in English and Hindi
MedShorts for pharmacists →
For field force

Scientific confidence in every call

Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.

  • Daily five-minute learning bursts
  • Quizzes and product certification
  • Compliant, trackable sharing
MedShorts for field force →
The connected care chain

One message, from the representative to the patient

When all three roles learn from the same source, the patient hears one consistent story about their treatment.

Field representative

Learns the evidence, passes certification, shares an approved MedShorts link.

Doctor

Reviews the update in minutes, prescribes with the latest guidance, shares patient material.

Pharmacist

Dispenses correctly and counsels on dose, timing, side-effects and adherence.

MedShorts hubShared evidence base, medical review, multi-language content and one analytics layer across all three audiences.See the programme model
Strategic pillars

Five things MedShorts is built on

Short, evidence-led content

Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.

Reach where people already are

Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.

Learning, not just reading

Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.

Insight for brand teams

Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.

Trust and compliance

Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.

India-first delivery

Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.

How it works

Receive, open, learn, act

Receive

A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.

Open

One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.

Learn

Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.

Act

Apply it in practice, share patient material, or continue to a full CME course.

Measure

Engagement flows into the brand dashboard and shapes the next content cycle.

Content formats

The right format for every minute available

Clinical shorts

Two-to-three-minute reads on a single clinical question.

KOL video bites

Expert perspectives in three-to-five-minute clips.

Journal digests

Landmark and recent trials summarised with key numbers.

Guideline snapshots

What changed, and what it means in clinic.

Quizzes & case challenges

Test and reinforce, with instant explanations.

Patient education

Leaflets and videos doctors and pharmacists can share.

Interactive tools

Lung-sound and ECG trainers, calculators and checklists.

Safety alerts

Interaction, storage and pharmacovigilance reminders.

Already live

A growing library across specialties

MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.

The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.

NeurologyCardio-metabolicRespiratoryOrthopaedicsOncologyWomen's healthCritical careDermatologyDentalOphthalmology

Browse the content library

Fewer, shorter and better-targeted messages, shared by everyone around the patient, do more than any single detailing call.The idea behind the MedShorts network

Bring your brand science to the whole care chain

Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.

Talk to our team